ULB Hôpital Erasme

Brussels 1070

1 studies enrolling now · 13 studies all time

What they study most

Adenocarcinoma, Pancreatic Ductal, Candidemia, Candidiasis, Invasive, Chronic Thromboembolic Pulmonary Hypertension, Hypertension, Pulmonary, Idiopathic Pulmonary Fibrosis, Influenza A, Metastatic Colorectal Cancer, Metastatic Pancreatic Adenocarcinoma, Mycoses, Prostatic Neoplasms, Castration-Resistant, Pulmonary Arterial Hypertension

Studies at this site

• A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC — Recruiting now
• A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling
• Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension — Running, not enrolling
• A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection — Stopped early
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections — Completed
• A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment — Stopped early
• A Study to Evaluate Long Term Safety and Efficacy of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE) — Completed
• Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer — Completed
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) — Stopped early